Search Results - "Ando, Masaharu"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Usefulness of Early-phase Peritoneal Lavage for Treating Severe Acute Pancreatitis by Matsumoto, Kazuyuki, Miyake, Yasuhiro, Nakatsu, Morihito, Toyokawa, Tatsuya, Ando, Masaharu, Hirohata, Mamoru, Kato, Hironari, Yamamoto, Kazuhide

    Published in Internal Medicine (01-01-2014)
    “…Objective To improve the prognosis of severe acute pancreatitis, preventing infectious complications, particularly infected pancreatic necrosis, is important…”
    Get full text
    Journal Article
  5. 5

    Overlap of IgG4-related Sclerosing Cholangitis and Primary Biliary Cirrhosis by Takemoto, Reika, Miyake, Yasuhiro, Harada, Kenichi, Nakanuma, Yasuni, Moriya, Akio, Ando, Masaharu, Hirohata, Mamoru, Yamamoto, Kazuhide

    Published in Internal Medicine (01-01-2014)
    “…We herein present a case of an overlap of immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) and primary biliary cirrhosis (PBC). A 61-year-old man was…”
    Get full text
    Journal Article
  6. 6

    Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia by Miyake, Yasuhiro, Ando, Masaharu, Kaji, Eisuke, Toyokawa, Tatsuya, Nakatsu, Morihito, Hirohata, Mamoru

    Published in Hepatology research (01-10-2008)
    “…Aim:  A low platelet count leads to dose reduction of interferon (IFN) and is associated with failure to achieve a sustained virological response (SVR) in…”
    Get full text
    Journal Article
  7. 7

    Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis by Miyake, Yasuhiro, Iwasaki, Yoshiaki, Kobashi, Haruhiko, Yasunaka, Tetsuya, Ikeda, Fusao, Takaki, Akinobu, Okamoto, Ryoichi, Takaguchi, Kouichi, Ikeda, Hiroshi, Makino, Yasuhiro, Ando, Masaharu, Sakaguchi, Kohsaku, Yamamoto, Kazuhide

    Published in Hepatology research (01-03-2009)
    “…Aim:  Antinuclear antibodies (ANA) are the main serologic markers of type 1 autoimmune hepatitis (AIH); however 20–30% of patients are negative for ANA. We…”
    Get full text
    Journal Article
  8. 8

    A case of hepatic angiomyolipoma difficult to distinguish from hepatocellular carcinoma by Takahara, Masahiro, Miyake, Yasuhiro, Matsumoto, Kazuyuki, Kawai, Daisuke, Kaji, Eisuke, Toyokawa, Tatsuya, Nakatsu, Morihito, Ando, Masaharu, Hirohata, Mamoru

    Published in World journal of gastroenterology : WJG (21-06-2009)
    “…We report a case of hepatic angiomyolipoma with uncommon clinical features. A 56-year-old man presented with a hepatic tumor in the caudate lobe. The tumor was…”
    Get full text
    Journal Article
  9. 9

    Long-term Combined Therapy with Very-low-dose Peginterferon and Ursodeoxycholic Acid Decreased the Spleen Size in a Patient with Hepatitis C Virus-related Cirrhosis by Anzai, Taiko, Miyake, Yasuhiro, Yasuhara, Hisae, Miyatake, Hirokazu, Asagi, Akinori, Moriya, Akio, Nakatsu, Morihito, Ando, Masaharu, Hirohata, Mamoru

    Published in Internal Medicine (01-01-2013)
    “…A 42-year-old woman with hepatitis C virus-related cirrhosis underwent peginterferon alpha-2b therapy combined with ribavirin but could not achieve a sustained…”
    Get full text
    Journal Article
  10. 10

    A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B by Matsumoto, Kazuyuki, Miyake, Yasuhiro, Miyatake, Hirokazu, Takahara, Masahiro, Imada, Takayuki, Yagi, Satoru, Toyokawa, Tatsuya, Nakatsu, Morihito, Ando, Masaharu, Hirohata, Mamoru

    Published in World journal of gastroenterology : WJG (07-04-2009)
    “…Of patients with severe exacerbation of chronic hepatitis B accompanied by jaundice and coagulopathy, 20%-30% have a fatal outcome. In this report, we describe…”
    Get full text
    Journal Article
  11. 11

    Partial Splenic Embolization Facilitates the Adherence to Peginterferon in Chronic Hepatitis C with Thrombocytopenia by Takahara, Masahiro, Miyake, Yasuhiro, Miyatake, Hirokazu, Imagawa, Atsushi, Nakatsu, Morihito, Ando, Masaharu, Hirohata, Mamoru, Yamamoto, Kazuhide

    Published in Internal Medicine (01-01-2011)
    “…Objective Platelet counts before starting the treatment affect the discontinuation and dose reduction of peginterferon in chronic hepatitis C. Thrombocytopenia…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Large waist circumference is a risk factor for reflux esophagitis in Japanese males by Yasuhara, Hisae, Miyake, Yasuhiro, Toyokawa, Tatsuya, Matsumoto, Kazuyuki, Takahara, Masahiro, Imada, Takayuki, Yagi, Satoru, Miyatake, Hirokazu, Nakatsu, Morihito, Ando, Masaharu, Hirohata, Mamoru

    Published in Digestion (01-01-2010)
    “…The prevalence of reflux esophagitis, which might lead to development of Barrett's esophagus and esophageal adenocarcinoma, has been increasing. The aim of…”
    Get more information
    Journal Article
  17. 17

    Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood by Miyake, Yasuhiro, Iwasaki, Yoshiaki, Kobashi, Haruhiko, Yasunaka, Tetsuya, Ikeda, Fusao, Takaki, Akinobu, Okamoto, Ryoichi, Takaguchi, Kouichi, Ikeda, Hiroshi, Makino, Yasuhiro, Sakaguchi, Kohsaku, Ando, Masaharu, Yamamoto, Kazuhide

    Published in Hepatology research (01-08-2009)
    “…Aim:  The peak age of the presentation of autoimmune hepatitis (AIH) is between 40 years and 50 years. Elderly patients have been reported to have higher…”
    Get full text
    Journal Article
  18. 18

    1905-P: Artificial Decline in HbA1c Level during Treatment of Hepatitis C with Interferon-Free, Direct-Acting Antiviral Regimen Combined with Ribavirin by MORIYA, AKIO, IWASAKI, YOSHIAKI, ANDO, MASAHARU

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…HbA1c is an important marker for glycemic control; however, not only plasma glucose levels but also RBCs' lifespan determines the value. Some of…”
    Get full text
    Journal Article
  19. 19
  20. 20